The Asia Cervical Cancer Screening Market will reach to US$3.76 billion by 2032 up from US$ 3.76 billion in 2023. This expected growth is going to be a CAGR 4.23% between 2024 and 2032. Women health and preventive medicine has been of most concern resulting into development and supporting cervical cancer screening campaigns, vaccination and treatment services with aim of eradicating cervical cancer.
Screening for cervical cancer has some differences depending on the available health facilities and policies within the respective countries. In developed countries, women are invited for screening in organized screening programmes; with most of them screened every 3- 5 years. But absolute coverage is still relatively low worldwide because of financial issues, poor infrastructure, and population traditions in LMICs. However, there is continued endeavour in developing better feasible means of screening in a resource constrained environment as in use of visual inspection with acetic acid (VIA). World health bodies have embarked on sensitization campaigns and enhancement of cervical cancer screening in order to decrease the prevalence of the ailment in the world.
Current development in the market includes automation of screening techniques through screening machines as well as molecular testing. Japanese companies also actively work on developing new sophisticated screening technologies so that the market is growing. However, great challenges such as the growth of an aging population and changing lifestyle keep influencing the occurrence in cervical cancer. Cervical cancer screening in Japan is efficient now, but authorities and health care providers are seeking for an increased accessibility of screening, especially in rural areas and the development of new approaches to improve the cervical cancer early detection and prevention.
In June 2022, Roche has launched a new HPV self-sampling solution that allows patients to collect their own vaginal samples for HPV screening at a healthcare facility. The samples are analyzed using the Roche cobas® HPV test on a Roche molecular instrument.
May 2024, The Genomics Institute-BGI Genomics launched a cervical cancer screening program at Remera Health Center in cooperation with the Rwanda Biomedical Center.
June 2023, Crowell & Moring International, Roche, TogetHER for Health, CAPED, and Jhpiego are founding the Asia-Pacific Women's Cancer Coalition to address the rise in breast and cervical cancer cases in the Asia-Pacific region.
2. HPV DNA Market
3. VIA (visual inspection with acetic acid) Market
2. Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Thailand
8. Indonesia
2. Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Indonesia
2. China
3. Thailand
4. Indonesia
2. Hologic Corporation
3. Becton
4. Siemens AG
5. Roche Diagnostics
6. Quest Diagnostics
7. Cardinal Health
Asia Cervical Cancer Screening Market Outlooks
Cervical cancer screening is a health promotion check aiming at identifying abnormal cells or cervical cancer at early stages in women. These are such techniques as the Pap smear test and human papillomavirus (HPV) testing. These tests involve testing of samples of cervix cells to determine if there are any precancerous conditions that if not treated can cause cancer. Screening ought to be routine to enhance detection of cervical cancer in its early stages to ensure that it is controlled right from the time it is discovered hence lowered mortality rates associated with cervical cancer.Screening for cervical cancer has some differences depending on the available health facilities and policies within the respective countries. In developed countries, women are invited for screening in organized screening programmes; with most of them screened every 3- 5 years. But absolute coverage is still relatively low worldwide because of financial issues, poor infrastructure, and population traditions in LMICs. However, there is continued endeavour in developing better feasible means of screening in a resource constrained environment as in use of visual inspection with acetic acid (VIA). World health bodies have embarked on sensitization campaigns and enhancement of cervical cancer screening in order to decrease the prevalence of the ailment in the world.
Driving Forces of the Asia Cervical Cancer Screening Market
Increasing awareness and government initiatives:
The governments of all Asian countries understand the significance of cervical cancer prevention and introduce cervical cancer screening programs at the national level. Many countries including South Korea, Singapore, and Thailand also introduced comprehensive campaigns to enhance the awareness about breast cancer and screening services. Some of the interventions comprise mass awareness campaigns, low cost or free cervical cancer checks, and cervical cancer screening as a part of a general package in the primary care. Also, non-governmental organizations and international health care organizations work with the local authorities to ensure that screening reaches the rural and underprivileged populations. These favorable governmental policies in addition to the growing awareness among the female populace of the province regarding early detection of cervical cancer fuel the growth of cervical Cancer Screening Market in Asia. The government has proposed the use of vaccines for girls in the age of 9-14 years for vaccination against the human papillomavirus (HPV) for cervical cancer. This initiative was announced by Union Finance Minister in the Interim Budget 2024-25.Technological advancements in screening methods:
Asia cervical cancer screening market is in the growing phase due to development in the screening techniques. This primary screening is being done by more advanced forms of cytopathological examination such as liquid based techniques, HPV DNA detection and computer aided screening. Hu et al forthcoming reviewed that by using these technologies, there is enhanced ability in the detection of precancerous lesions with higher sensitivity and specificity. Similarly, portable screening devices, and point-of-care tests reduce the challenges of cervical cancer screening in the rural areas. The use of artificial intelligence and machine learning to analyse screening results improve the diagnostic tools accuracy and efficiency as well. These technologies are gradually becoming available and more affordable and as such the cervical cancer screening gains more popularity in the different forms of healthcare facilities in Asia.Growing healthcare expenditure and infrastructure development:
New healthcare consumers are appearing as Asian middle class increases and disposable rate grows resulting in higher healthcare expenditures. This has the flair of enabling more profound investment on healthcare actions such as cancer screening stations. Several Asian countries focus on establishing multispecialty cancer care facilities and enhancement of modernisation in existing healthcare centers having cancer diagnosis amenities. There is also provision of the cervical cancer screening services that is provided by the private healthcare sector. In addition, enrolment in health insurance plans where preventive care such as cancer screening examinations is included as part of the policy benefit is slowly gaining ground in several Asian countries. Enhanced cares health policies as well as care funding aids the large population in getting cervical cancer screening hence boosting market demand. China’s total health expenditure in 2022 was over 8.5 trillion yuan, including government, collective, and private out-of-pocket spending.Japan Cervical Cancer Screening Market
Japan cervical cancer screening market is well developed and the focus is made on the preventive measures. Japan has developed a cervical cancer screening program for the entire nation where women of 20 years and above are advised to undergo pap test regularly. The country has over these years passed through changes from conventional to liquid-based cytology and has adopted HPV testing in screening. However, participation rate of screening has traditionally been lowering in Japan than in other comparable countries and continuous efforts have been made for raising the level of awareness towards screening.Current development in the market includes automation of screening techniques through screening machines as well as molecular testing. Japanese companies also actively work on developing new sophisticated screening technologies so that the market is growing. However, great challenges such as the growth of an aging population and changing lifestyle keep influencing the occurrence in cervical cancer. Cervical cancer screening in Japan is efficient now, but authorities and health care providers are seeking for an increased accessibility of screening, especially in rural areas and the development of new approaches to improve the cervical cancer early detection and prevention.
Asia Cervical Cancer Screening Company Analysis
Abbott Laboratories, Hologic Corporation, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health are the main actors in the Asia Cervical Cancer Screening industry.Asia Cervical Cancer Screening Company News
Feb 2024: BD announced a partnership with Camtech Health to offer the first-ever at-home cervical cancer screening option for women in Singapore.In June 2022, Roche has launched a new HPV self-sampling solution that allows patients to collect their own vaginal samples for HPV screening at a healthcare facility. The samples are analyzed using the Roche cobas® HPV test on a Roche molecular instrument.
May 2024, The Genomics Institute-BGI Genomics launched a cervical cancer screening program at Remera Health Center in cooperation with the Rwanda Biomedical Center.
June 2023, Crowell & Moring International, Roche, TogetHER for Health, CAPED, and Jhpiego are founding the Asia-Pacific Women's Cancer Coalition to address the rise in breast and cervical cancer cases in the Asia-Pacific region.
Type - Market has been covered from 3 viewpoints:
1. Pap smear Market2. HPV DNA Market
3. VIA (visual inspection with acetic acid) Market
Pap smear Market - 8 Country have been covered
1. Japan2. Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Thailand
8. Indonesia
HPV DNA Market - 7 Country have been covered
1. Japan2. Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Indonesia
VIA (visual inspection with acetic acid) Market - 4 Country have been covered
1. India2. China
3. Thailand
4. Indonesia
Companies have been covered from 4 viewpoints
- Overviews
- Recent Developments & Strategies
- Product Portfolio & Product Launch in Last 1 Year
- Revenue
Company Covered
1. Abbott laboratories2. Hologic Corporation
3. Becton
4. Siemens AG
5. Roche Diagnostics
6. Quest Diagnostics
7. Cardinal Health
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
5. Porter’s Five Forces
6. SWOT Analysis
7. Asia pacific Cervical Cancer Screening Analysis
8. Asia Cervical Cancer Test (Screening) Analysis
9. By Countries - Asia Cervical Cancer Test Market & Population Share Analysis
10. Japan - Cervical Cancer Test Analysis
11. South Korea - Cervical Cancer Tests Analysis
12. Singapore - Cervical Cancer Tests Analysis
13. Malaysia - Cervical Cancer Test Analysis
14. India - Cervical Cancer Test Analysis
15. China - Cervical Cancer Test Analysis
16. Thailand - Cervical Cancer Test Analysis
17. Indonesia - Cervical Cancer Test Analysis
18. Company Analysis
Companies Mentioned
- Abbott laboratories
- Hologic Corporation
- Becton
- Siemens AG
- Roche Diagnostics
- Quest Diagnostics
- Cardinal Health
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 3.76 Billion |
| Forecasted Market Value ( USD | $ 5.46 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 7 |
